Apoptosis-detecting radioligands: current state of the art and future perspectives
- PMID: 15138718
- DOI: 10.1007/s00259-004-1555-4
Apoptosis-detecting radioligands: current state of the art and future perspectives
Abstract
This review provides a critical and thorough overview of the radiopharmaceutical development and in vivo evaluation of all apoptosis-detecting radioligands that have emerged so far, along with their possible applications in nuclear medicine. The following SPECT and PET radioligands are discussed: all forms of halogenated Annexin V (i.e. (123)I-labelled, (124)I-labelled, (125)I-labelled, (18)F-labelled), (99m)Tc/(94m)Tc-labelled Annexin V derivatives using different chelators and co-ligands (i.e. BTAP, Hynic, iminothiolane, MAG(3), EDDA, EC, tricarbonyl, SDH) or direct (99m)Tc-labelling, (99m)Tc-labelled Annexin V mutants and (99m)Tc/(18)F-radiopeptide constructs (i.e. AFIM molecules), (111)In-DTPA-PEG-Annexin V, (11)C-Annexin V and (64)Cu-, (67)Ga- and (68)Ga-DOTA-Annexin V. In addition, the potential role and clinical relevance of anti-PS monoclonal antibodies and other alternative apoptosis markers are reviewed, including: anti-Annexin V monoclonal antibodies, radiolabelled caspase inhibitors and substrates and mitochondrial membrane permeability targeting radioligands. Nevertheless, major emphasis is placed on the group of Annexin V-based radioligands, in particular (99m)Tc-Hynic-Annexin V, since this molecule is by far the most extensively investigated and best-characterised apoptosis marker at present. Furthermore, the newly emerging imaging modalities for in vivo detection of programmed cell death, such as MRI, MRS, optical, bioluminescent and ultrasound imaging, are briefly described. Finally, some future perspectives are presented with the aim of promoting the development of potential new strategies in pursuit of the ideal cell death-detecting radioligand.
Comment in
-
Role of ultrasound in the detection of apoptosis.Eur J Nucl Med Mol Imaging. 2005 May;32(5):622. doi: 10.1007/s00259-004-1736-1. Eur J Nucl Med Mol Imaging. 2005. PMID: 15726355 No abstract available.
Similar articles
-
Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.Eur J Nucl Med. 1999 Oct;26(10):1251-8. doi: 10.1007/s002590050580. Eur J Nucl Med. 1999. PMID: 10541822
-
Role of ultrasound in the detection of apoptosis.Eur J Nucl Med Mol Imaging. 2005 May;32(5):622. doi: 10.1007/s00259-004-1736-1. Eur J Nucl Med Mol Imaging. 2005. PMID: 15726355 No abstract available.
-
Structural requirements for in vivo detection of cell death with 99mTc-annexin V.J Nucl Med. 2005 May;46(5):807-15. J Nucl Med. 2005. PMID: 15872355 Free PMC article.
-
99mTc-Labeled hydrazinonicotinamide-cysteine-annexin A5.2010 Jan 13 [updated 2010 Mar 4]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jan 13 [updated 2010 Mar 4]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641826 Free Books & Documents. Review.
-
Molecular imaging of cell death.Methods. 2009 Jun;48(2):178-87. doi: 10.1016/j.ymeth.2009.03.022. Epub 2009 Apr 9. Methods. 2009. PMID: 19362149 Review.
Cited by
-
Intraoperative detection of cell injury and cell death with an 800 nm near-infrared fluorescent annexin V derivative.Am J Transplant. 2006 Oct;6(10):2321-31. doi: 10.1111/j.1600-6143.2006.01469.x. Epub 2006 Jul 25. Am J Transplant. 2006. PMID: 16869796 Free PMC article.
-
Site-specific labeling of annexin V with F-18 for apoptosis imaging.Bioconjug Chem. 2008 Aug;19(8):1684-8. doi: 10.1021/bc800164d. Epub 2008 Jul 16. Bioconjug Chem. 2008. PMID: 18627198 Free PMC article.
-
Automated radiosynthesis of [(18)F]ML-10, a PET radiotracer dedicated to apoptosis imaging, on a TRACERLab FX-FN module.Mol Imaging Biol. 2013 Feb;15(1):12-8. doi: 10.1007/s11307-012-0574-y. Mol Imaging Biol. 2013. PMID: 22752653
-
Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects.EJNMMI Res. 2011 Nov 17;1(1):26. doi: 10.1186/2191-219X-1-26. EJNMMI Res. 2011. PMID: 22214377 Free PMC article.
-
PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.Eur J Nucl Med Mol Imaging. 2007 Feb;34(2):247-58. doi: 10.1007/s00259-006-0199-y. Epub 2006 Sep 22. Eur J Nucl Med Mol Imaging. 2007. PMID: 17021816
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials